We are live on ! Find out more
DTIL icon

Precision BioSciences

63 hedge funds and large institutions have $291M invested in Precision BioSciences in 2019 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 17 increasing their positions, 6 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

183% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 6

81% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 16

26% more funds holding

Funds holding: 5063 (+13)

0.11% more ownership

Funds ownership: 1.35%1.46% (+0.11%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

18% less capital invested

Capital invested by funds: $357M → $291M (-$65.4M)

Holders
63
Holders Change
+13
Holders Change %
+26%
% of All Funds
1.37%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
29
Increased
17
Reduced
6
Closed
16
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
VP
1
venBio Partners
California
$56.5M
Fidelity Investments
2
Fidelity Investments
Massachusetts
$49.5M
Franklin Resources
3
Franklin Resources
California
$27.7M +$13M +32,291 +81%
RCM
4
RA Capital Management
Massachusetts
$24.4M
ACH
5
ArrowMark Colorado Holdings
Colorado
$15.4M +$4.23M +10,516 +37%
CI
6
Cowen Inc
New York
$14.4M +$1.01M +2,512 +7%
Adage Capital Partners
7
Adage Capital Partners
Massachusetts
$11.9M
Wells Fargo
8
Wells Fargo
California
$11.7M +$4.74M +11,774 +67%
BlackRock
9
BlackRock
New York
$8.41M +$7.13M +17,709 +512%
Capital World Investors
10
Capital World Investors
California
$8.28M
DP
11
DSAM Partners
United Kingdom
$7.83M +$6.93M +17,205 +688%
LCM
12
Laurion Capital Management
New York
$6.86M
CAM
13
Cormorant Asset Management
Massachusetts
$6.2M -$4.19M -10,417 -40%
Vanguard Group
14
Vanguard Group
Pennsylvania
$5.66M +$4.72M +11,734 +469%
SFM
15
Sphera Funds Management
Israel
$4.44M +$1.48M +3,667 +49%
Ameriprise
16
Ameriprise
Minnesota
$3.88M +$578K +1,436 +17%
VC
17
Vivo Capital
California
$3.72M
HLA
18
Hamilton Lane Advisors
Pennsylvania
$3.63M +$3.68M +9,137 New
KCM
19
Kornitzer Capital Management
Kansas
$2.61M
Geode Capital Management
20
Geode Capital Management
Massachusetts
$1.82M +$1.84M +4,579 New
Victory Capital Management
21
Victory Capital Management
Texas
$1.81M +$1.52M +3,768 +475%
Principal Financial Group
22
Principal Financial Group
Iowa
$1.65M +$662K +1,645 +66%
VIA
23
Vident Investment Advisory
Georgia
$1.55M +$1.57M +3,898 New
Alyeska Investment Group
24
Alyeska Investment Group
Illinois
$1.55M -$447K -1,110 -22%
State Street
25
State Street
Massachusetts
$1.34M +$1.88M +4,672 New

DTIL Hedge Fund Activity: Q2 2019 in Review

63 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Precision BioSciences (DTIL) for Q2 2019, worth a combined $291M — down 18% from $357M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new DTIL positions and 16 closed out — a net gain of 13 holders — while 17 added to existing stakes and 6 trimmed.

The largest buyer was Franklin Resources, adding an estimated $13M. The largest seller was Janus Henderson Group, exiting entirely with an estimated $8.97M sold.

  • 63 institutional investors held Precision BioSciences (DTIL) as of Q2 2019, up from 50 in Q1 2019.
  • Funds reported $291M of Precision BioSciences stock for Q2 2019, down 18% quarter-over-quarter.
  • 29 funds opened new Precision BioSciences positions in Q2 2019 and 16 closed out, a net change of +13 holders.
  • The largest Precision BioSciences buyer in Q2 2019 was Franklin Resources, an estimated $13M added.
  • The largest Precision BioSciences seller in Q2 2019 was Janus Henderson Group, an estimated $8.97M sold.

Based on aggregated 13F filings for Q2 2019.